Sir, Carbapenems are considered as last-line clinical antibiotics used to treat severe human infections caused by MDR Gram-negative bacteria. Carbapenemase-producing Enterobacteriaceae (CPE) leading to carbapenem resistance or carbapenem non-susceptibility have spread in human settings worldwide in recent years and are associated with major public health concerns. 1 First detections of VIM-1 carbapenemase-producing Salmonella enterica subsp. enterica serovar Infantis (Salmonella Infantis) and Escherichia coli isolates in livestock farms in Germany in 2011 raised concern about their real prevalence in animals and their potential to be transferred to human settings. 2, 3 Indeed, Salmonella is a wellknown zoonotic pathogen commonly transferred via contaminated food products. 4 Among them, Salmonella Infantis is one of the leading causes of human salmonellosis in Europe. 4 In Germany, Salmonella Infantis ranked as the third most common cause in 2011-15 (German Infectious Diseases Notification Database 'SurvNet', Robert Koch Institute, Berlin, accessed October 2016); however, the number of salmonellosis cases caused by this serovar remains low (2.2% in 2011-15; https://survstat.rki.de, accessed October 2016). Carbapenemase-producing Salmonella are still rarely described in humans; 5 however, this genus may play a role in spreading carbapenemase-harbouring plasmids to other Enterobacteriaceae, as hypothesized for plasmids pRH-R27 (from Salmonella Infantis isolate R27) and pRH-R178 (from E. coli isolate R178) originating from a German swine farm (S2) in 2011. 6, 7 In the framework of routine diagnostic, monitoring and control programmes, the National Reference Laboratory for Salmonella in Germany received 145 Salmonella Infantis isolates (4.5%) in 2015 (33.8%, primary production; 38.6%, food; 13.1%, feed; 14.5%, other sources). In routine antimicrobial susceptibility testing (in concordance with the European Commission Implementing Decision 2013/652/EU) one of these Salmonella Infantis strains isolated from minced pork meat produced in Germany (15-SA01028) showed microbiological resistance (non-WT phenotype) to meropenem (MIC 0.5 mg/L), imipenem (MIC 4 mg/L) and ertapenem (MIC 0.12 mg/L) using the microdilution method [CLSI guidelines, CLSI M07-A9 and following EUCAST epidemiological cut-off values (ECOFFs), http://www.eucast.org]. This isolate and another Salmonella Infantis strain isolated in 2016 from a sick piglet (16-SA00749) that showed decreased susceptibility to meropenem (MIC 0.12 mg/L, but assessed as WT according to EUCAST ECOFFs) were analysed by WGS. Subsequent testing of isolate 16-SA00749 against imipenem and ertapenem revealed MICs of 4 and 0.25 mg/L, respectively.
Genomic DNA of the isolates was extracted using the PureLink genome) contigs. Bioinformatic analysis using tools from the Center for Genomic Epidemiology (http://www.genomicepidemiology.org) 9 revealed that both isolates belonged to MLST-ST32 and contained replicons of incompatibility groups IncHI2A and IncHI2. In both isolates a bla VIM-1 carbapenemase-encoding gene was responsible for the resistance phenotype. The bla VIM-1 gene was located on a class 1 integron identical to that found on pRH-R27 (LN555650.1) containing resistance gene cassettes bla VIM-1 -aacA4-aadA1 in its variable region (additionally confirmed by Sanger sequencing). 3 A further AmpC b-lactamase-encoding bla ACC-1 gene and genes conferring resistance to aminoglycosides (strA, strB), phenicols (catA1) and sulphonamides (sul1) could be identified. This genotype has already been described for pRH-R27; 2, 6 thus, the 300 bp paired-end reads were mapped against this plasmid using CLC Genomics Workbench 8.0. Read mapping resulted in consensus sequences with 100% (15-SA01028) and 96% (16-SA00749) identity to pRH-R27. The 4% difference in consensus sequence of 16-SA00749 is based on a deletion of a 12 kb region associated with plasmid maintenance genes (klaA, klaB and klaC). However, as in the cases of pRH-R27 and 15-SA01028, all the detected resistance genes were located on the plasmid. In contrast to previously described VIM-1-producing Salmonella Infantis (ST32) isolates R3, R25 and R27, which were non-serotypeable regarding the White-Kauffmann-Le Minor scheme and non-motile, 2 the recently detected Salmonella Infantis isolates could be typed by classical serology and expressed both H phases. However, identical XbaI PFGE patterns of 15-SA01028 and 16-SA00749 to R27 (Figure 1a ) and the presence of highly related plasmids (size 300 kb confirmed in S1-nuclease PFGE; Figure 1b ) in both swine and swine-derived meat hint towards a link between the affected farms and vertical transmission from primary production into the food chain. This and the fact that minced pork is consumed raw as Mett (a popular German dish) underline that the occurrence of CPE in food-producing animals indeed might pose a risk of colonization with CPE through consumption of raw meat.
These findings in recent Salmonella isolates and recurrent detection of an R178-related VIM-1-producing E. coli clone 10 show that highly related VIM-1-harbouring isolates/mobile genetic elements have been circulating or re-emerging in German pig production in recent years, possibly triggered by co-selection since carbapenems are not licensed for veterinary use in Germany.
The wide spread of MDR isolates in humans, animals and their environments obstructs the understanding of transmission routes. In the case of CPE, we are currently observing the initial spread between these reservoirs. Limited spread of CPE from non-human sources allows a more detailed assessment of transmission routes and mechanisms of antimicrobial resistant determinants, as carbapenemase-encoding genes can be regarded as marker genes in this context. Thus, the thorough investigation of each CPE from non-human sources is of considerable interest in order to understand their possible spread and to develop adequate risk management strategies. Increased awareness and specific monitoring (such as the voluntary monitoring on carbapenemaseproducing microorganisms laid down in European Commission Decision 2013/652/EU) are needed to assess the extent of the possible spread. Sensitive detection methods for carbapenemresistant or non-susceptible isolates including Salmonella from livestock animals and food are therefore needed. 1 It has been suggested that persister cells might be one of the reasons for the failure of antibiotic treatment and might contribute to the evolution of antibiotic resistance. 2 Formation of persister cells against polymyxins (polymyxin B and colistin), which are regarded as last-resort antibiotics to treat MDR Gram-negative pathogens, has also been reported. 3 In this study, we studied variations in the rate of formation of persisters against colistin in Acinetobacter baumannii isolates causing bloodstream infections and its associations with genotype and clinical results.
We collected 45 strains of colistin-susceptible A. baumannii (colistin MICs, 1 or 2 mg/L by method of broth microdilution), which were isolated from patients with bloodstream infections in the Samsung Changwon Hospital (Changwon, South Korea). Colistin was administered to treat infections. These A. baumannii strains showed 10 different STs in MLST analysis according to the Oxford scheme (Figure 1a) . 4 The most prevalent ST was ST191 (n " 19), followed by ST208 (n " 9) and ST357 (n " 6). Most of them belonged to clonal complex 208 (CC208), except four strains of three STs (ST229, ST1252, and ST1430). CC208 corresponds to global clone 2 (GC2), the most prevalent carbapenem-resistant A. baumannii clone worldwide including South Korea.
5 ST229 also belongs to a recently identified epidemic clonal lineage. 6 A persister cell formation assay was performed as previously described, 7 with minor modifications. Cells were grown until the exponential phase (OD 600 "0.5) and then exposed to colistin (5% MIC) at 37 C. Two colonies from each sample were re-inoculated into fresh LB broth and in vitro antimicrobial susceptibility tests were performed to ensure that the MIC values had not changed. As a result, the survival rates of persister cells showed continuous variations among strains. The highest survival rate obtained was 5.75%10
#5

+5.26%10
#5 in SCH32, and 10 strains showed no persister cell formation at all (Figure 1a) . Although ST368 and ST229 strains showed very low or no persister cell formation, no distinct relationship between STs and persister cell formation was detected. For example, the most prevalent STs, ST191 and ST208, showed very diverse persister cell formation rates.
We also compared the rates of formation of persister cells with 7 day treatment results (failed or successful). Mean bacterial survival rates were found to be higher in strains with that could not be treated (0.63%10 #5 versus 1.22%10
#5
), but the differences were not significant (P " 0.1097) (Figure 1b) . However, it is to be noted that 7 day treatment failure (defined as a patient's death or bacterial survival) was not observed in 8 out of the 10 strains that showed no persister cell formation (Figure 1a) .
Persisters have been reported in many bacterial pathogens, but few reports have been published regarding the formation of persister cells in A. baumannii. 2, 8 To the best of our knowledge, persistence against colistin has not been reported at all. A recent study even suggested that colistin might kill Escherichia coli persisters and enhance the activity of fluoroquinolones. 9 However, the results of our study showed that persister cells against colistin are formed in A. baumannii isolates. So far, no definitive mechanisms of persistence against colistin in A. baumannii have been proposed. The persister cell formation may not be associated with genotypes or diseases caused by A. baumannii infection. No significant
